Indian-origin consultant charged in $450K insider trading scheme
Darpan News Desk IANS, 12 Nov, 2021 11:35 AM
An Indian-origin partner in a global consulting firm has been arrested and charged in an alleged insider trading scheme that netted him about $450,000, according to federal officials.
"Puneet Dikshit has been charged with serious felonies for his alleged conduct" of exploiting insider information about a pending acquisition, New York Federal Prosecutor Damian Williams said on Wednesday.
He was produced before Federal Magistrate Judge Kevin Fox, who set a bail of $1 million.
According to a LinkedIn profile, he worked for McKinsey & Company, one of the largest global consulting firms.
Court papers said that Dikshit's company had been hired by Goldman Sachs to advise it on the acquisition of GreenSky, a company traded on the NASDAQ stock exchange, and that he had used insider information to trade options on that company's stocks.
After making some small trades, he bought call options - which are essentially bets on the stock prices going up - in accounts in his and his spouse's name for about $24,647 about two days before the Goldman Sach's announcement on September 15 that it was acquiring GreenSky in a $2.24 billion deal, according to court papers.
After the announcement when the stock prices shot up, he sold the call options at a profit of 1,829 per cent, netting about $450,000, court papers said.
"Dikshit now faces significant federal charges, which should serve as a warning to others considering similar conduct," said Michael J. Driscoll, the assistant director of the Federal Bureau of Investigation.
Dikshit, 40, is facing two separate charges, each of which carries a maximum prison sentence of 20 years.
Besides the criminal case filed by the prosecutor, he is facing a civil case launched by the Securities and Exchange Commission seeking monetary penalties.
The lure of easy money from insider trading, using confidential information to manipulate stock prices or make a profit, has been the undoing of several leading figures in the US world, among them several people of Indian origin.
The most famous among them to get entangled in insider trading is Rajat Gupta, who was the first foreign-born person to head McKinsey.
He was sentenced to two years after being convicted of insider trading in 2012 and spent about a year and a half in prison and the rest of the term under house arrest.
Anil Kumar, a senior partner and director at McKinsey, who was involved in the same case turned approver and testified against Gupta. He was sentenced to two years of probation.
Local authorities have conducted investigations after New York University (NYU) evacuated multiple buildings due to bomb threats. The locations were soon evacuated, according to the university. Police conducted a search and later issued an all clear, reports Xinhua news agency.
International flight arrivals are expected to rise 11 per cent on Monday over a similar day in October at Newark Liberty and John F. Kennedy international airports, with 253 flights scheduled to arrive, according to the Port Authority of New York and New Jersey, Xinhua news agency reported.
Paramhans Desai, 38, was shot when he arrived at a house in McDonough in Georgia state on the evening of November 4 as he tried to make an arrest, local county Sheriff Reginald Scandrett said at a news conference. The attacker pulled away and drew a handgun and shot Desai before fleeing in a car, Scandrett said.
Along Canada's boundary, cross-border hockey rivalries were upended. Churches that had members on both sides of the border were suddenly cut off from each other.
Available in a range of standards, including gold and silver, the special collectors' coin was designed by Heena Glover and features an image of a lotus, India's national flower, alongside one of Gandhi's most famous quotes -- "My life is my message".
The pill was licensed for adults 18 and older who have tested positive for COVID-19 and have at least one risk factor for developing severe disease, such as obesity or heart disease. Patients with mild-to-moderate COVID-19 would take four pills of the drug, known molnupiravir, twice a day for five days.
